FAMPYRA 10 mg, extended-release tablet 56 tablets, CIP 3400921725506
Active ingredients: Dalfampridine
Commercialized according to BDPMDispensing in France: Prescription only
Extended-release tablet56 tablets, CIP 3400921725506orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FAMPYRA 10 mg, comprimé à libération prolongée
- Pharmaceutical form
- comprimé à libération prolongée
- Route of administration
- orale
- Presentation description
- 4 flacon(s) polyéthylène haute densité (PEHD) de 14 comprimé(s)
- Marketing authorisation holder
- MERZ THERAPEUTICS
- Reimbursement according to BDPM
- 15 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Apr 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62483787CIP72172550CIP133400921725506Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FAMPRIDINEcomprimé | 10 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.